 this material may not be published broadcast rewritten or redistributed 2020 fox news network llc all rights reserved all market data delayed 20 minutes fox news medical correspondent dr marc siegel weighs in get all the latest news on coronavirus and more delivered daily to your inbox sign up here the experimental coronavirus treatment remdesivir has generated positive data in a trial of the antiviral organized by thenational institute of allergy and infectious diseases niaid according to developer gilead sciences we understand that the trial has met its primary endpoint and that niaid will provide detailed information at an upcoming briefing said gilead in a statement released wednesday the niaid study is a double blind placebo controlled trial encompassing more than 800 patients according to a recent document posted by gilead on its website the study involves patients with critical severe and moderate covid 19 systems according to the document remdesivir what to know about potential coronavirus treatment shares of gilead rose more than 4 percent on wednesday morning on heelsof the news in an open letter sent out on april 4 gilead ceo daniel o day explained that multiple clinical trials have been set up to determine whether remdesivir is a safe and effective treatment for covid 19 the niaid and the world health organization are running global trials according to o day in its statement released wednesday gilead said that it will share additional remdesivir data from the company s open label phase 3 simple trial in patients with severe covid 19 disease shortly this study will provide information on whether a shorter 5 day duration of therapy may have similar efficacy and safety as the 10 day treatment course evaluated in the niaid trial and other ongoing trials it said gilead expects data at the end of may from the second simple study evaluating the 5 and 10 day dosing durations of remdesivir in patients with moderate covid 19 disease experimental coronavirus drug remdesivir is showing early promise research says in the u s remdesivir is still awaiting regulatory approval as a coronavirus treatment the antiviral was previously used to treat ebola patients and has been garnering massive attention as the world scrambles to contain the coronavirus pandemic experts however have warned that people should not take drugs unless prescribed by a doctor remdesivir is one of a number of drugs in the spotlight as the u s scrambles to contain the pandemic in a press conference last month president trump and fda commissioner dr stephen hahn described several approaches under testing such as chloroquine a drug long used to treat malaria and remdesivir the various trials of remdesivir have comeunder intense scrutiny experimental coronavirus treatment remdesivir flops in china trial reports remdesivir did not show benefits in a trial in china according to reports that emerged last week citing draft documents published accidentally by the world health organization the financial times reported thatthe study was the first randomized clinical trial of the antiviral to treat coronavirus health news site stat also reported on the document noting that the data from the study are likely imperfect the trial it reported was ended prematurely which could have affected the results in a statement obtained by fox news at the time a gilead sciences spokesperson said the who documents included inappropriate characterizations of the study gilead gives update on experimental coronavirus treatment earlier this month it was revealed that china suspendedtwo clinical trials for remdesivir saying that the epidemic has been controlled well at present an april 15 notice on the u s national library of medicine apos s clinicaltrialswebsitesaid the trials were postponed as no eligible patients can be recruited however another small research study recentlyrevealedthat remdesivir is showing early promise in the battle against the coronavirus outbreak army war on covid 19 saves soldiers lives with remdesivir anti viral drug the study which was published in thenew england journal of medicine was supported by gilead click here for complete coronavirus coverage as of wednesday morning more than 3 13 million coronavirus cases have been diagnosed worldwide at least 1 013 168 of which are in the u s the disease has accounted for at least 218 456 deaths around the world including at least 58 355 people in the u s fox news chris ciaccia contributed to this article follow james rogers on twitter jamesjrogers get a daily look at what s developing in science and technology throughout the world subscribed you ve successfully subscribed to this newsletter this material may not be published broadcast rewritten or redistributed 2020 fox news network llc all rights reserved all market data delayed 20 minutes 